Finance & Acquisitions

Cannabis operators aren’t alone in worrying about consolidation. Consumers interviewed across nine established adult-use markets praised legalization for improving safety, access, and social acceptance, but many also saw regulatory costs and corporate concentration pushing small businesses aside. Participants also questioned whether cannabis tax revenue has delivered promised community benefits and worry large corporations eventually could shape policy in their favor.

Vireo Growth’s proposed acquisition of Planet 13 would add 36 dispensaries, a high-profile Las Vegas superstore, and greater density in Florida. But the all-stock deal comes as Planet 13 reports declining revenue, widening losses, and a narrower operating footprint. The assets offer clear strategic value, yet Vireo’s projected scale, including roughly 265 dispensaries across fifteen states, depends on multiple transactions closing and integrating successfully.

Cannabis banks continue monitoring deposits, sales, licenses, ownership, and compliance after an account opens. Medical marijuana’s move to Schedule III may add new documentation and reporting questions, especially for businesses serving both medical and adult-use markets. Here, two bankers advise how to strengthen your banking relationship and avoid common pitfalls during the rescheduling transition.

Cannabis investors and lenders have not disappeared, but their expectations have changed. Operators seeking capital now must demonstrate clean financials, positive cash flow, disciplined management, and a business model that works under current market and regulatory conditions — not one dependent on eventual federal reform.

An industry-wide end to 280E would do more than lower tax bills. A Schedule III shift could reshape cash flow, capital planning, debt management, and operational investment for cannabis businesses. Finance leaders who model scenarios now and decide how they would deploy released cash may be better positioned to strengthen their companies before competition and capital demands intensify.

Trulieve will begin trading on the NYSE after executing a strategic corporate restructuring to maintain a 100-percent medical consolidated footprint.

High revenue might catch a buyer’s eye, but it takes more than just strong numbers to close a deal. As federal reclassification reshapes the cannabis industry, acquirers are looking beyond EBITDA to determine a business's true worth. Here are the hidden operational drivers that maximize a dispensary’s valuation and help build a highly scalable, premium acquisition target.

Expanding your cannabis operation is an exciting milestone, but it’s also the exact moment your bank starts paying closer attention. Every new license, state, or investor changes your company's risk profile in the eyes of financial institutions. If left unmanaged, this newfound complexity can unexpectedly put your banking relationships in jeopardy. Two bankers reveal the hidden risks of rapid expansion, why your bank suddenly has so many questions, and how to successfully scale your business without losing access to crucial financial services.

The historic federal shift reclassifying medical marijuana to Schedule III brings undeniable progress, offering long-awaited tax relief from Section 280E. Yet, despite the initial market excitement, rescheduling is not a cure-all for the industry’s deep-rooted liquidity crisis. Cash buyers remain scarce, transactions rely heavily on seller financing, and regulatory fragmentation persists. True competitive advantage in a mature market won’t come from waiting on Washington. It will come from corporate architecture. Here’s why some cannabis operators are looking past policy hype and leveraging independent buyouts to achieve the ultimate business goal: a tax-free exit.

In a move that signals massive consolidation in the B2B events space, Apollo Global Management has agreed to acquire Emerald Holding Inc. — parent company of MJBizCon — in a $1.5-billion all-cash deal. The transaction will take the publicly traded Emerald private, merging its portfolio with Questex LLC to create a unified experiential media platform. While the deal reflects Apollo’s broader interest in specialized markets rather than a specific cannabis play, the shift raises critical questions about the future of the industry’s largest trade show. Will MJBizCon thrive under new institutional ownership, or drift within a larger, more diverse portfolio?